Trial intelligence / Profile preview

Central Insulin Action on Peripheral Sensitivity in Lean vs Overweight

NCT02468999Completed

Sponsor
University Hospital Tübingen
Start
Jan 2015
Primary completion
Dec 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, double-blind trial in insulin resistance (IR) comparing Insulin Nasal Spray with Placebo Nasal Spray (2 arms). Primary endpoints: Glucose Infusion Rate, Endogenous Glucose Production and 1 more. Started Jan 2015; status: completed.

02

Drugs

human insulin
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on NCT02468999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02468999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call